These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7495969

  • 1. Viral iatrogenic contamination and safety of biologicals.
    Horaud F.
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S5-9. PubMed ID: 7495969
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human and animal vaccine contaminations.
    Pastoret PP.
    Biologicals; 2010 May; 38(3):332-4. PubMed ID: 20456974
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk mitigation strategies for viral contamination of biotechnology products: consideration of best practices.
    Rosenberg AS, Cherney B, Brorson K, Clouse K, Kozlowski S, Hughes P, Friedman R.
    PDA J Pharm Sci Technol; 2011 May; 65(6):563-7. PubMed ID: 22294578
    [Abstract] [Full Text] [Related]

  • 10. Managing unexpected events in the manufacturing of biologic medicines.
    Grampp G, Ramanan S.
    BioDrugs; 2013 Aug; 27(4):305-16. PubMed ID: 23529766
    [Abstract] [Full Text] [Related]

  • 11. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S, Ball R, Braun MM.
    Vaccine; 2008 May 02; 26(19):2428-32. PubMed ID: 18406499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A risk assessment on extraneous virus contamination in a viral vaccine production environment justifies waiving of in vivo testing.
    Westergaard UB, van Overeem Hansen B, Rud KA, Nielsen C, Stawski G, Hasløv KR.
    Biologicals; 2018 Nov 02; 56():9-12. PubMed ID: 30173936
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of PCR for extranous agent testing in avian vaccines.
    Ottiger HP.
    Dev Biol (Basel); 2002 Nov 02; 111():23-6. PubMed ID: 12678221
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Opinion on adventitious agents testing for vaccines: why do we worry so much about adventitious agents in vaccines?
    Sheets RL.
    Vaccine; 2013 Jun 10; 31(26):2791-5. PubMed ID: 23528414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.